5-112753783-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000038.6(APC):​c.-18-1090T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.662 in 152,044 control chromosomes in the GnomAD database, including 33,620 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as other (no stars).

Frequency

Genomes: 𝑓 0.66 ( 33620 hom., cov: 32)

Consequence

APC
NM_000038.6 intron

Scores

2

Clinical Significance

other no assertion criteria provided O:1

Conservation

PhyloP100: 0.465

Publications

12 publications found
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • APC-related attenuated familial adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Turcot syndrome with polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.776 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APCNM_000038.6 linkc.-18-1090T>C intron_variant Intron 1 of 15 ENST00000257430.9 NP_000029.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APCENST00000257430.9 linkc.-18-1090T>C intron_variant Intron 1 of 15 5 NM_000038.6 ENSP00000257430.4

Frequencies

GnomAD3 genomes
AF:
0.662
AC:
100514
AN:
151926
Hom.:
33589
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.708
Gnomad AMI
AF:
0.632
Gnomad AMR
AF:
0.708
Gnomad ASJ
AF:
0.592
Gnomad EAS
AF:
0.797
Gnomad SAS
AF:
0.730
Gnomad FIN
AF:
0.538
Gnomad MID
AF:
0.665
Gnomad NFE
AF:
0.631
Gnomad OTH
AF:
0.672
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.662
AC:
100602
AN:
152044
Hom.:
33620
Cov.:
32
AF XY:
0.661
AC XY:
49131
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.709
AC:
29388
AN:
41474
American (AMR)
AF:
0.708
AC:
10823
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.592
AC:
2053
AN:
3470
East Asian (EAS)
AF:
0.796
AC:
4112
AN:
5166
South Asian (SAS)
AF:
0.730
AC:
3524
AN:
4826
European-Finnish (FIN)
AF:
0.538
AC:
5673
AN:
10554
Middle Eastern (MID)
AF:
0.673
AC:
198
AN:
294
European-Non Finnish (NFE)
AF:
0.631
AC:
42847
AN:
67950
Other (OTH)
AF:
0.668
AC:
1409
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1728
3456
5184
6912
8640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.647
Hom.:
76224
Bravo
AF:
0.679
Asia WGS
AF:
0.755
AC:
2622
AN:
3478

ClinVar

Significance: other
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Familial colorectal cancer Other:1
-
Systems Biology Platform Zhejiang California International NanoSystems Institute
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.5
DANN
Benign
0.76
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2439591; hg19: chr5-112089480; API